Attached files
| file | filename |
|---|---|
| 8-K - CURRENT REPORT - CEL SCI CORP | cvm_8k.htm |
EXHIBIT 99
 |
Contact:
Gavin de Windt
Investor Relations Manager
Phone: 703 506-9460
Email address: gdewindt@cel-sci.com
|
CEL-SCI Receives $2.1 Million from Warrant Exercises
Vienna, VA, June 27, 2018 - CEL-SCI
Corporation (NYSE American:
CVM), in response to
shareholder questions, updates its shareholders on the amount of
money received from warrant exercises since April 1, 2018.
Since that time CEL-SCI has received $2,133,677 through the
exercise of warrants by investors to purchase the Company's common
stock. The number of shares outstanding is
19,518,106.
About CEL-SCI Corporation
CEL-SCI's work is focused on finding the best way to activate the
immune system to fight cancer and infectious diseases. The Company
has operations in Vienna, Virginia, and in/near Baltimore,
Maryland.